Genmab A GMAB
NASDAQ GMAB
$34.74 +0.21 (+0.61%)
At close: Sep 18, 2026 · 4:00 PM EDT

Genmab A (GMAB) Prepaid Assets (2023 - 2025)

Genmab A's (GMAB) quarterly Prepaid Assets came in at $65.0 million in Q4 2025, up 172.89% on a YoY basis from $23.8 million in Q4 2024, and up 172.89% quarter-over-quarter from $23.8 million in Q4 2024.

Analysis

Genmab A (GMAB) Prepaid Assets (2023 - 2025) Analysis & Trends

Genmab A (GMAB) has reported Prepaid Assets for 3 consecutive years, with $65.0 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 172.89% year-over-year to $65.0 million; the trailing twelve-month figure through Dec 2025 stood at $65.0 million (up 172.89% YoY), and the FY2025 full-year result was $65.0 million, up 172.89% from the prior year.
  • Prepaid Assets rose to $65.0 million in Q4 2025 per GMAB's latest filing, from $23.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $65.0 million in Q4 2025 and bottomed at $22.6 million in Q4 2023.
  • Historically, Prepaid Assets has averaged $37.2 million across 3 years, with a median of $23.8 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Prepaid Assets climbed 5.2% in 2024, then surged 172.89% in 2025.
  • Over 3 years, Prepaid Assets stood at $22.6 million in 2023, then climbed by 5.2% to $23.8 million in 2024, then soared by 172.89% to $65.0 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $65.0 million, $23.8 million, and $22.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 Genmab A 2.23 Bn 728.64 Mn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 65.00 Mn
Dec 31, 2024 23.82 Mn
Dec 31, 2023 22.64 Mn